Cardiam’s business plan is based on a technology that aims to help physicians determine the proper drug and dosage for patients suffering from cardiac diseases.
Published on: 02-17-2012
Cardiam, a team that evolved in Georgia Tech's
TI:GER® (Technological Innovation: Generating Economic Results) Program,
placed third overall in the 2012 Georgia Bowl® Business Plan Competition and
won first place for their presentation.
Cardiam’s business plan is based on a technology that aims to help
physicians determine the proper drug and dosage for patients suffering from
cardiac diseases. Currently, it is difficult for physicians to predict how
individual patients will react to certain anti-platelet drugs.
Cardiam’s rapid, point-of-care diagnostic device analyzes a small
sample of a patient’s blood using cutting-edge techniques in optics and
microfluidics to detect patient response to common anti-platelet drugs.
Physicians will be able to use the device to provide a customized dosage for
each patient, ensuring correct treatment.
Cardiam team member Melissa Li has been developing her team's
technology during her doctoral studies in biomedical engineering at Georgia
Tech. Other members of the Cardiam team include: Tom Ausman and Daniel Ng, both
Georgia Tech MBA students, and Jesse David and Lance Hochhauser, Emory
University law students.
These students all participate in TI:GER, a collaboration between
Georgia Tech and Emory Law School that brings together science and engineering
PhD, MBA, and law students to work on commercializing innovative technologies.
The Georgia Bowl is sponsored by Kennesaw State University and attracts
teams from leading colleges and universities. The competition is based on ideas
for new businesses that these teams have developed at their respective schools.
Cardiam competed with teams from Georgia colleges as well as Johns Hopkins
University, University of Illinois-Chicago, University of Louisville, and
University of Manitoba.
Director of Communications
Assistant Director of Communications